Direct Bilirubin, but not Indirect Bilirubin, is Associated with Short-term Adverse Events in HFpEF
Conclusion: DBIL, but not IBIL, was associated with short-term ominous prognosis in patients with HFpEF. Hence, DBIL may be the superior predictor for prognosis in HFpEF.PMID:38310459 | DOI:10.2174/0115665232273115240102043640
Source: Current Gene Therapy - Category: Genetics & Stem Cells Authors: Sunying Wang Yan Chen Hanghao Ma Yuwei Wang Manqing Luo Xianwei Xie Qingyong Yang Kaijin Lin Meihua Lin Lin Lin Ping Chen Qiaowen Zheng Fuqing Sun Source Type: research
More News: Bilirubin | Cardiology | Cardiovascular | Gene Therapy | Genetics | Heart | Heart Failure | Statistics | Study